10x Genomics
TXG
51.80
-5.58
-9.72%
10x Genomics
US · TXG
#1311 by market cap
Listed 2019
51.80
-5.58
-9.72%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
J.P. Morgan Remains a Hold on 10x Genomics (TXG)TipRanks · 2026/8/11
-
Rating change
Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $45Market Newswire · 2026/7/8
-
Stephens Initiates 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $65Market Newswire · 2026/11/12
-
Rating change
Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $110Market Newswire · 2026/10/7
-
Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/11/9
-
Rating change
CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $100Market Newswire · 2026/10/12
-
Rating change
Piper Sandler Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $42Market Newswire · 2026/7/1
-
Rating change
Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $50Market Newswire · 2026/8/7
-
Rating change
CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $50Market Newswire · 2026/7/14
-
Rating change
RBC Capital Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $70Market Newswire · 2026/9/1
-
Rating change
CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $60Market Newswire · 2026/8/10
-
Rating change
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $80Market Newswire · 2026/10/9
-
A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $60 to $100Market Newswire · 2026/11/7
-
Rating change
William Blair Maintains 10x Genomics(TXG.US) With Buy RatingMarket Newswire · 2026/9/30
-
UBS Maintains 10x Genomics(TXG.US) With Hold Rating, Maintains Target Price $61Market Newswire · 2026/11/9
-
Rating change
TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $47Market Newswire · 2026/7/15
-
Rating change
A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $50 to $53Market Newswire · 2026/8/8
-
Rating change
J.P. Morgan Reaffirms Their Hold Rating on 10x Genomics (TXG)TipRanks · 2026/10/17
-
J.P. Morgan Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $65Market Newswire · 2026/11/9
-
Rating change
Leerink Partners Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $90Market Newswire · 2026/9/29
-
Rating change
Morgan Stanley Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $20.5Market Newswire · 2026/5/12
-
Rating change
A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $23 to $32Market Newswire · 2026/5/9
-
Rating change
CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/6/10
-
Rating change
Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $40Market Newswire · 2026/6/24
-
Rating change
BofA Securities Maintains 10x Genomics(TXG.US) With Hold RatingMarket Newswire · 2026/5/14
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.
10x Genomics discussion 0 comments